Dr. Michael Goodman, MD
Claim this profileSalisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
Studies Prostate Cancer
Studies Cancer
7 reported clinical trials
18 drugs studied
Area of expertise
1Prostate Cancer
CDK12 positive
Stage IV
CHEK2 positive
2Cancer
Stage IV
Affiliated Hospitals
Clinical Trials Michael Goodman, MD is currently running
High Dose Testosterone
for Prostate Cancer
This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which are genetically unstable because of DNA repair deficiency and this is a prospective study to test that hypothesis
Recruiting3 awards Phase 2
MGE + ADT
for Prostate Cancer
It is estimated that one-third of the more than 7 million deaths from cancer worldwide are attributable to potentially modifiable risk factors, with 374,000 deaths preventable through diet modification alone. Diet supplementation for the prevention or treatment of cancer is attractive, as implementation is relatively easy, even in populations with reduced incomes and resources. Grape extracts or active components isolated from grapes have received attention as chemopreventive or therapeutic agents based upon their anti-proliferative, anti-inflammatory, and anti-oxidant properties. Evidence from preclinical trials also suggests that muscadine grape products may decrease systemic inflammation. This study builds upon promising preclinical and clinical evidence to determine if the addition muscadine grape extract (MGE) to androgen deprivation therapy (ADT) improves symptoms in men with prostate cancer.
Recruiting0 awards Phase 28 criteria
More about Michael Goodman, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Michael Goodman, MD has experience with
- High Dose Testosterone
- LHRH Analogue
- Abiraterone Acetate
- Apalutamide
- Prednisone
- Cabazitaxel
Breakdown of trials Michael Goodman, MD has run
Prostate Cancer
Hemorrhagic Shock
Wounds and Injuries
Renal Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Goodman, MD specialize in?
Michael Goodman, MD focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved CDK12 positive patients, or patients who are Stage IV.
Is Michael Goodman, MD currently recruiting for clinical trials?
Yes, Michael Goodman, MD is currently recruiting for 5 clinical trials in Salisbury North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Michael Goodman, MD has studied deeply?
Yes, Michael Goodman, MD has studied treatments such as High dose testosterone, LHRH Analogue, Abiraterone Acetate.
What is the best way to schedule an appointment with Michael Goodman, MD?
Apply for one of the trials that Michael Goodman, MD is conducting.
What is the office address of Michael Goodman, MD?
The office of Michael Goodman, MD is located at: Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury, North Carolina 28144 United States. This is the address for their practice at the Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.